Quality of life and safety of adjuvant Mistletoe in patients with gastric carcinoma, a Naturopathic Research
Mistletoe is a plant grown in Europe and some North American countries, it contains an immune-modulating molecule such as lectins that acts on several pathways such as increasing the number of immune cells such as macrophages and neutrophils, phagocytic activities, and natural killer cells.
The topic of today's article is quality of life and safety of adjuvant Mistletoe in patients with gastric carcinoma, a Naturopathic Research.
This research was published in the BMJ Complement Altern Med in 2012 and this is the link to that research https://pubmed.ncbi.nlm.nih.gov/23033982/
In this research, 32 operated gastric cancer patients were involved whereby Mistletoe A injections were given subcutaneously 3 days a week postoperatively from day 7 to week 24 at increasing doses.
At the end of this research, these patients were assessed using the quality-of-life questionnaires, blood work (such as complete blood count, liver enzymes various cytokines),
It was found that the quality of life of these patients improved a lot as compared to the pretreatment status meaning better energy overall performance and the activity of daily living. Blood work showed a good safety profile with normal liver enzymes and cytokines levels.
So, in conclusion, the use of Mistletoe showed a promising positive effect on those patients, and it is recommended to perform more research on that topic in the future.
Have any questions? Need help?